Newsroom

Finansavisen 14. januar 2025

Milliardoppkjøp for gründersuksess -Vi har vært imponerte hele veien , sier bioMérieux-topp Celine Roger-Dalbert. Det franske konsernet legger 1,6 milliarder ...
Read More

Finansavisen 13. januar 2025

Kjøpes av fransk magnum-investor SpinChip prises til 1,6 milliarder kroner når selskapet kjøpes av bioMérieux. Les hele artikkelen her.
Read More

Finansavisen 13. januar 2025

Milliardoppkjøp for gründersuksess: Prisen åttedoblet på to år – Vi har vært imponert hele veien, sier BioMérieux-topp Celine Roger-Dalbert. Det franske ...
Read More

PRESS RELEASE – SpinChip Diagnostics to be Acquired by bioMérieux

Transaction Valuation: SpinChip valued at NOK 1,624 million (EUR 138 million), making it one of the largest MedTech transactions in ...
Read More

SpinChip Diagnostics ASA secures NOK 60 million in private placement

Oslo, Norway, 19 November 2024 – SpinChip Diagnostics ASA (“SpinChip”) is pleased to announce the completion of its financing round, ...
Read More

PRESS RELEASE – SpinChip announces publication of the APACE study in the Journal of the American College of Cardiology (JACC)

With very high diagnostic accuracy, the SpinChip point-of-care (POC) test demonstrated performance comparable to the best-validated central laboratory-based assays. This ...
Read More

PRESS RELEASE – SpinChip Diagnostics ASA secures NOK 145 million in private placement

Oslo, Norway, [22] March 2024 — SpinChip Diagnostics ASA (“SpinChip”), a pioneering diagnostics company developing a next-generation point-of-care platform for ...
Read More

Finansavisen 15. mars 2024

Henter inn fransk magnuminvestor: BioMérieux prises til 12 milliarder europå Paris-børsen og har sine røtter i Louis Pasteurs laboratorium. Nå ...
Read More

PRESS RELEASE – SpinChip Diagnostics ASA receives NOK 115 million investment from bioMérieux SA

SpinChip Diagnostics has developed a small immunoassays Point of Care (POC) Analyzer that delivers the same diagnostics performance as most ...
Read More

PRESS RELEASE – SpinChip Secures NOK 43 million in Financing Round

Oslo, Norway, 8 January 2024 — SpinChip Diagnostics ASA (“SpinChip”), a pioneering diagnostics company developing a next-generation point-of-care platform for in vitro diagnostics, ...
Read More

SpinChip Diagnostics AS becomes SpinChip Diagnostics ASA

On December 4th, 2023 SpinChip Diagnostics was converted into a public limited liability company. The name of the company is ...
Read More

ISO 13485:2016 certification

We are excited to share that SpinChip Diagnostics has successfully obtained ISO 13485:2016 certification for our Quality Management System. In ...
Read More

PRESS RELEASE – SpinChip Diagnostics’ Point-of-Care platform demonstrates diagnostic performance on par with state-of-the-art clinically validated laboratory analyzers

Oslo, (8 June 2023) — SpinChip Diagnostics AS (SpinChip), a pioneering diagnostics company developing a next-generation point-of-care (POC) platform for in ...
Read More

Finansavisen 5. mai 2023

Kuttet prisen 60 prosent – fikk inn ny Sveits-investor Christen Sveaas og Patientsky-gründer Jespen Melin Ganc-Petersen måtte godta et solid ...
Read More

PRESS RELEASE – SpinChip Secures NOK 65.4 million in Financing Round

The financing round finances the design verification and sample comparison study as well as a retrospective study with 3,600 frozen ...
Read More

Finansavisen 7. februar 2023

Jakter kvart milliard med priskutt Christen Sveaas, Investinor og MP Pensjon må trolig akseptere redusert verdsetting når SpinChip skal hente ...
Read More

Welcome Glenn Gundersen

We are excited to welcome Glenn Gundersen to the SpinChip team as our new Head of Clinical and Medical Affairs. He will ...
Read More

Shareholder Letter, July 2022

Dear shareholder, It has been an eventful year so far, however the next couple of years are expected to be ...
Read More

Cartridge

The SpinChip cartridge holds integrated both liquid and dried reagents. The microfluidic designs are specifically designed to process the sample ...
Read More

Finansavisen 29. juni 2021

Satser 30 millioner kroner på ekspress-blodprøver SpinChip slet på sin forrige emisjonsrunde, men denne gangen ble det klaff. Selskapet henter ...
Read More